Skip to main content
. 2024 Jan 10;45(3):292–301. doi: 10.1017/ice.2023.231

Table 3.

Association of Medical Exposures and Acquisition of Carbapenemase-Producing Organisms During Initial Months of an Outbreak, by Carbapenemase Gene Detected, Long-Term Acute-Care Hospital A (LTACHA), Florida, July 13–December 7, 2017

Medical Exposures bla VIM bla KPC
Adjusted RR a 95% CI P Value Adjusted RR a 95% CI P Value
Oral vancomycin 1.22 0.92–1.63 .170 1.37 0.98–1.93 .066
Feeding tube 1.07 1.02–1.14 .022 1.18 1.01–1.39 .041
BiPAP/CPAP 0.94 0.89–0.98 .015 0.96 0.76–1.22 .744
Hemodialysis 1.02 0.93–1.12 .695 1.14 0.93–1.40 .195
Mechanical ventilation 1.09 0.97–1.23 .163 1.05 0.89–1.25 .519
PICC line 1.05 0.93–1.18 .437 1.21 1.02–1.45 .030
Speech therapy 1.12 0.97–1.29 .127 1.08 0.64–1.85 .752
Tracheostomy 1.13 1.03–1.24 .010 1.07 0.91–1.25 .408
≥ 3 indwelling devices b 1.14 1.03–1.26 .014 1.21 1.02–1.43 .025

Note. VIM, Verona-integron-encoded metallo-β-lactamase; KPC, Klebsiella pneumoniae carbapenemase; LOS, length of stay; ICU, intensive care unit; BiPAP/CPAP, bilevel/continuous positive airway pressure; PICC, peripherally inserted central catheter. P values were based on a 2-tailed probability and a significance level set at α < .05.

a

All models were adjusted for age, sex, length of stay, and intensive care unit stay.

b

Device cutoff was determined a priori; the referent group for medical exposures was the absence of the device and the referent group for ≥3 devices was 0–2 devices. Device history was collected through procedure logs provided by LTACH-A on a monthly basis.